ArticlePharmaceutics2020

Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production.

Mónica Vicente-Pascual et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.